about
Targeted Nanotheranostics for Future Personalized Medicine: Recent Progress in Cancer TherapyEchogenic Glycol Chitosan Nanoparticles for Ultrasound-Triggered Cancer TheranosticsROS-generating TiO2 nanoparticles for non-invasive sonodynamic therapy of cancerAntitumor therapeutic application of self-assembled RNAi-AuNP nanoconstructs: Combination of VEGF-RNAi and photothermal ablation.Supramolecular hydrogel formation based on inclusion complexation between poly(ethylene glycol)-modified chitosan and alpha-cyclodextrin.Preparation and characterization of self-assembled nanoparticles of heparin-deoxycholic acid conjugates.Tumor-targeting hyaluronic acid nanoparticles for photodynamic imaging and therapy.Polymeric nanoparticles for protein kinase activity.Complex adaptive therapeutic strategy (CATS) for cancer.Identification of a peptide ligand recognizing dysfunctional endothelial cells for targeting atherosclerosis.Prevention effect of orally active heparin conjugate on cancer-associated thrombosis.Anionic amino acid-derived cationic lipid for siRNA delivery.Tumor targeting chitosan nanoparticles for dual-modality optical/MR cancer imaging.Cellular uptake pathway and drug release characteristics of drug-encapsulated glycol chitosan nanoparticles in live cells.A mesoporous silica nanoparticle with charge-convertible pore walls for efficient intracellular protein delivery.Matrix metalloproteinase sensitive gold nanorod for simultaneous bioimaging and photothermal therapy of cancer.Accurate sequential detection of primary tumor and metastatic lymphatics using a temperature-induced phase transition nanoparticulate systemPhotosensitizer-conjugated human serum albumin nanoparticles for effective photodynamic therapyMolecular targeting of atherosclerotic plaques by a stabilin-2-specific peptide ligand.Direct thrombus imaging as a means to control the variability of mouse embolic infarct models: the role of optical molecular imaging.In situ dose amplification by apoptosis-targeted drug delivery.Facilitated intracellular delivery of peptide-guided nanoparticles in tumor tissues.Near-infrared fluorescence imaging using a protease-specific probe for the detection of colon tumors.Characterization of partial ligation-induced carotid atherosclerosis model using dual-modality molecular imaging in ApoE knock-out miceDesign of a multicomponent peptide-woven nanocomplex for delivery of siRNA.Bioreducible carboxymethyl dextran nanoparticles for tumor-targeted drug delivery.Directed molecular assembly into a biocompatible photosensitizing nanocomplex for locoregional photodynamic therapy.Measurement of MMP Activity in Synovial Fluid in Cases of Osteoarthritis and Acute Inflammatory Conditions of the Knee Joints Using a Fluorogenic Peptide Probe-Immobilized Diagnostic Kit.Direct Imaging of Cerebral Thromboemboli Using Computed Tomography and Fibrin-targeted Gold Nanoparticles.Theranostic nanoparticles based on PEGylated hyaluronic acid for the diagnosis, therapy and monitoring of colon cancer.Polymeric nanoparticle-based activatable near-infrared nanosensor for protease determination in vivo.Improved antitumor activity and tumor targeting of NH(2)-terminal-specific PEGylated tumor necrosis factor-related apoptosis-inducing ligand.Super pH-sensitive multifunctional polymeric micelle for tumor pH(e) specific TAT exposure and multidrug resistance.Design of a platform technology for systemic delivery of siRNA to tumours using rolling circle transcription.Multicomponent, peptide-targeted glycol chitosan nanoparticles containing ferrimagnetic iron oxide nanocubes for bladder cancer multimodal imaging.Activatable imaging probes with amplified fluorescent signals.Engineered polymers for advanced drug delivery.Engineered Human Ferritin Nanoparticles for Direct Delivery of Tumor Antigens to Lymph Node and Cancer Immunotherapy.Lipid-based emulsion system as non-viral gene carriers.TNF-α gene silencing using polymerized siRNA/thiolated glycol chitosan nanoparticles for rheumatoid arthritis.
P50
Q26744832-FBE45AF7-61E1-4630-AA6C-9C5584E5A362Q27300964-AF3D7D5A-58BD-4C70-B0B7-2C5C7CAF630EQ27331599-0FCFDBA6-9B40-4D08-9806-7490980794FFQ30833380-904A5456-D8D0-4392-9A1A-4843F50C592FQ30968338-4C828E6B-9AFE-434B-9714-CF329F7B6135Q30978344-7E88C473-F7B7-4B58-9BA1-206CA3029096Q31049125-530A3C49-9FF9-4897-BDCB-3636C93281AFQ33279634-15B24370-18F8-4B0E-8564-A2C79CF02D33Q33357409-8DF27B04-E828-4C93-AC0F-434FE6376FC1Q33357737-71C33F42-DBD5-4538-8E36-53AA783C8B9BQ33415527-B0C6E35E-FDF5-495A-A732-6C6A00B1BC48Q33476595-FEBC6A92-F2F2-472F-9232-6554F221BFE7Q33536724-EE489487-86DF-4A51-82A5-B3272934E818Q33541103-51976FF8-ED8D-40B6-9D96-320380B2BD06Q33572706-FC1B9E34-9E26-4838-9370-437E98320FC2Q33742611-3AC898D0-4964-4C3C-B524-B5C50F8DA183Q33800703-0B98A775-0A54-4DAE-A17D-C1A0CF2BA795Q33895996-BD1ED625-D24D-4734-BA9E-AC423A72F244Q33969150-38C41363-32F0-4D06-961E-4CB7CD0D15BFQ34054618-3107F597-2C82-48A5-8A23-FA010ED26461Q34201002-B78220C6-7372-4E5A-BBCC-2D0DFEBF0016Q34219275-C94006CD-C7E4-4C86-AF58-E0B106958FA5Q34494056-0A783C94-9A0F-45F8-9C58-09EA04BBC25BQ34998689-6306CE62-3264-4546-A42A-05DECDE0B0CBQ35112531-4F2ABD63-FC76-43CF-B574-05FA0B4E4CF4Q35154383-A7238CD4-BAB0-4062-B01A-5A904C173AA9Q35600996-EB8EF759-D6AC-43B6-8185-5D22B5D5F348Q35780984-43932E25-88DE-49CB-92E1-9785CE816F07Q35868873-8018D216-8925-4192-A561-FE7F5D08DE71Q36742896-9736F334-8AB5-4E4E-ABE2-A7EF544C9EF8Q36746517-1FA27C35-C4E0-4D58-9475-8B93B23D36B2Q36777316-678A1E04-9034-4AF6-9CDF-9B17F180FC31Q37016869-6E5C72C5-CB71-4DD7-8BA7-C22621D4AC7CQ37031856-8C1CD10D-1411-4959-B3A1-B5B8EEA4367CQ37229797-8DE33B98-CE7D-4C22-B535-53B218E08F96Q37273318-B7288CE2-95D5-4D8A-BA5B-0945FF649C6EQ37314701-C5DFDF2D-1930-460E-826A-41B0038B573EQ37325317-2388BC07-E987-4F1F-B69E-ED5F7C2EDF8BQ37496822-4E51AC5B-0F5C-4E3B-B132-9D1F3601804CQ37562070-1825F5F3-316C-4EB3-A17F-0B4A0F098E8E
P50
name
Ick Chan Kwon
@ast
Ick Chan Kwon
@en
Ick Chan Kwon
@nl
type
label
Ick Chan Kwon
@ast
Ick Chan Kwon
@en
Ick Chan Kwon
@nl
prefLabel
Ick Chan Kwon
@ast
Ick Chan Kwon
@en
Ick Chan Kwon
@nl